SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Mediwound Ltd (MDWD)

Add MDWD Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 2/1/2016 3:12:46 PM - Followers: 1 - Board type: Free - Posts Today: 0

MediWound Ltd. is a biotechnology niche specialty company focused on developing, manufacturing and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid™ NexoBrid™ successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
MDWD News: MediWound Granted U.S. Patent for MWPC003 for the Treatment of Connective Tissue Diseases 12/20/2016 07:00:00 AM
MDWD News: Abstract Highlighting NexoBrid® in Burn Mass Casualties Awarded “Best Poster” at the International Disaster and Military... 11/18/2016 08:00:00 AM
MDWD News: Report of Foreign Issuer (6-k) 11/14/2016 07:03:03 AM
MDWD News: MediWound Reports Third Quarter 2016 Financial Results 11/14/2016 06:45:00 AM
MDWD News: MediWound to Host Third Quarter 2016 Financial Results Conference Call on November 14, 2016 at 8:30 a.m. Eastern Time 11/04/2016 08:00:00 AM